10-Q: Abacus Life Reports Mixed Q1 Results Amidst Revenue Growth and Increased Expenses

Sentiment:

Quarterly Report 13 May 2024 8:41 AM

Abacus Life, Inc. experienced significant revenue growth in Q1 2024, primarily driven by active management, but also saw a net loss due to increased operating expenses and non-cash charges.

Capital raiseThe company filed a registration statement with the SEC for a proposed public offering of its common stock on May 10, 2024.The number of shares to be sold and the price range for the proposed offering have not yet been determined.

Worse than expectedThe company's net income decreased from a profit of $7.625 million to a loss of $1.275 million year over year.The company's operating expenses increased significantly, offsetting revenue gains.

Summary

Abacus Life, Inc. reported a net loss of $1.275 million for the first quarter of 2024, compared to a net income of $7.625 million in the same period last year.
The company's total revenue increased to $21.487 million, up from $10.273 million in Q1 2023, primarily driven by a substantial increase in active management revenue.
Operating expenses rose significantly to $16.513 million, compared to $2.255 million in the prior year, due to increased sales and marketing, general and administrative costs, and non-cash charges.
The company's gross profit was $18.766 million, a notable increase from $9.784 million in Q1 2023.
The company's cash and cash equivalents increased to $65.387 million as of March 31, 2024, up from $25.589 million at the end of 2023.
The company repurchased 778,766 shares of its common stock at a cost of $8.807 million during the quarter.
The company's life settlement policies at fair value were $125.489 million, with a face value of $506.956 million.

Sentiment

Score: 5

Explanation: The document presents a mixed picture with strong revenue growth offset by increased expenses and a net loss. The company's future outlook is uncertain, and the potential capital raise adds another layer of complexity. The sentiment is neutral to slightly negative.

Positives

The company experienced significant revenue growth, particularly in active management.
Gross profit increased substantially year-over-year.
Cash and cash equivalents increased significantly, providing a stronger financial position.
The company successfully issued additional senior unsecured notes, raising capital for general corporate purposes.

Negatives

The company reported a net loss of $1.275 million for the quarter.
Operating expenses increased dramatically, offsetting revenue gains.
The company experienced a loss on the change in fair value of debt of $2.713 million.
The company's effective tax rate was 1151.0% for the quarter, primarily driven by limitations on stock-based compensation deductions.

Risks

The company's operating expenses are increasing significantly, which could impact future profitability.
The company is exposed to market risk through its market-indexed debt instruments.
The company's life settlement policies are subject to valuation risk, which could impact financial results.
The company's effective tax rate is highly variable and could impact future profitability.
The company is subject to legal and regulatory risks inherent in the life settlement industry.

Future Outlook

The company may seek additional equity or debt financing in the future. The company believes that its current cash and cash equivalents as well as planned life settlement policy trading activity will be sufficient to support its operating and debt service needs for the 12 months following the filing of this Quarterly Report on From 10-Q.

Management Comments

The company leverages its strong market position, highly efficient origination platform, and proprietary technology to drive revenue and profitability.
The company has established policies and guidelines with respect to its purchase of universal life, whole life and convertible term life insurance policies.
The company's guidelines are designed to allow the company to target the life insurance policies that it believes have the most upside potential to generate attractive risk-adjusted returns.

Industry Context

The company operates in the life settlements industry, which involves the purchase and sale of existing life insurance policies. The company's performance is influenced by factors such as mortality rates, interest rates, and regulatory changes. The company is a leading buyer of life insurance policies in the U.S. and leverages its market position and technology to drive revenue and profitability.

Comparison to Industry Standards

The company's revenue growth in active management is significant compared to industry averages, indicating a strong market position.
The company's increase in operating expenses is higher than industry benchmarks, suggesting potential inefficiencies or aggressive growth strategies.
The company's use of fair value accounting for life settlement policies is consistent with industry practices, but the valuation process is complex and subject to estimation risk.
The company's debt levels are higher than some competitors, which could increase financial risk.
The company's stock repurchase program is a common practice among public companies, but the timing and amount of repurchases can impact shareholder value.

Related Party Transactions

The company has a related-party relationship with Nova Trading (US), LLC and Nova Holding (US) LP.
The company earns service revenue related to policy and administrative services on behalf of the Nova Funds.
The company also originates policies for the Nova Funds and earns origination fees for these services.
The SPV Purchase and Sale Note and the Sponsor PIK Note are also considered related party transactions.

Stakeholder Impact

Shareholders may be concerned about the net loss and increased operating expenses.
Employees may be impacted by changes in the company's financial performance.
Customers may be affected by changes in the company's service offerings.
Suppliers may be impacted by changes in the company's purchasing patterns.
Creditors may be concerned about the company's debt levels and ability to repay.

Next Steps

The company intends to commence the public offering following completion of the SEC review process, subject to market and other conditions.
The company will continue to monitor and manage its operating expenses.
The company will continue to evaluate and optimize its life settlement policy portfolio.

Key Dates

Date	Description
2020-07-22	The Company purchased 224,551 units of an unrelated insurance technology company's Series Seed Preferred units for $750,000.
2020-12-21	The Company purchased 207,476 shares of a separate unrelated insurance technology company's Series B-1 preferred stock for $500,000.
2021-11-01	The Company purchased a $250,000 convertible promissory note in an unrelated insurance technology company.
2022-01-07	The Company purchased an additional $250,000 convertible promissory note in an unrelated insurance technology company.
2022-03-31	LMATT Series 2024, Inc. issued $10,166,900 in market-indexed private placement notes.
2022-09-02	LMA Income Series, LP formed and issued partnership interests.
2022-09-16	LMATTS Growth Series 2.2024, Inc. issued $2,333,391 in market-indexed private placement notes and LMATTS Growth and Income Series 1.2026, Inc. issued $400,000 in market-indexed private placement notes.
2022-10-01	The Company purchased an additional convertible promissory note in the same unrelated insurance technology company for $500,000.
2023-01-31	LMA Income Series II, LP formed and issued partnership interests.
2023-06-30	LMA acquired Abacus through the Abacus Merger.
2023-07-05	The Company entered into an Asset Purchase Agreement to acquire certain insurance policies from Abacus Investment SPV, LLC.
2023-10-01	The Compensation Committee approved the issuance of 2,468,500 restricted stock units (RSUs) to executives, employees and directors as part of the Companys 2023 Long-Term Equity Compensation Incentive Plan.
2023-11-10	The Company issued $35,650,000 in fixed rate senior unsecured notes.
2023-12-11	The board of directors authorized a stock repurchase program.
2024-02-15	The Company issued an additional $25,000,000 as part of the previously issued Fixed Unsecured Notes.
2024-02-29	The Compensation Committee approved the issuance of 108,000 RSUs and 345,263 stock options to certain executives under the Companys Long-Term Incentive Plan.
2024-03-31	End of the reporting period for the quarterly report.
2024-05-03	The registrant had 63,925,316 shares of common stock outstanding.
2024-05-10	The Company filed a registration statement with the SEC for a proposed public offering of its common stock.

Keywords

life settlements, active management, origination, insurance policies, financial results, revenue growth, operating expenses, debt, fair value, stock repurchase

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.